Literature DB >> 22659189

Syndecans play dual roles as cell adhesion receptors and docking receptors.

Mi-Jung Kwon1, Bohee Jang, Jae Youn Yi, Inn-Oc Han, Eok Soo Oh.   

Abstract

Syndecan are a family of cell surface heparan sulfate proteoglycans that act as cell surface receptors. Most cell surface receptors have a limited number and type of ligand interactions, responding only to the binding of (a) specific ligand(s). In contrast, syndecans can interact with various numbers and types of ligands, and thus play more diverse roles than others. Various syndecan functions have not yet been fully classified and categorized, but we herein review previous studies suggesting that syndecans play dual function as cell surface receptors by acting as both adhesion receptors and docking receptors. Through this dual regulatory function, syndecans are capable of regulating both intra- and extracellular activities, potentially altering a variety of cell behaviors.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659189     DOI: 10.1016/j.febslet.2012.05.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.

Authors:  Bohee Jang; Hyejung Jung; Sojoong Choi; Young Hun Lee; Seung-Taek Lee; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2017-08-16       Impact factor: 5.157

2.  A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation.

Authors:  Tobias Pasqualon; Jessica Pruessmeyer; Sarah Weidenfeld; Aaron Babendreyer; Esther Groth; Julian Schumacher; Nicole Schwarz; Bernd Denecke; Holger Jahr; Pascale Zimmermann; Daniela Dreymueller; Andreas Ludwig
Journal:  Cell Mol Life Sci       Date:  2015-04-26       Impact factor: 9.261

3.  Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Connie G Glasgow; Yoshihiko Ikeda; Jing-Ping Lin; Gang Zheng; Joel Moss
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

4.  Fosmid-based structure-function analysis reveals functionally distinct domains in the cytoplasmic domain of Drosophila crumbs.

Authors:  Sven Klose; David Flores-Benitez; Falko Riedel; Elisabeth Knust
Journal:  G3 (Bethesda)       Date:  2013-02-01       Impact factor: 3.154

5.  E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy.

Authors:  Pinelopi Gkogkou; Evangelia Peponi; Dimitrios Ntaskagiannis; Samuel Murray; Asimo Demou; Ioannis Sainis; Elli Ioakeim; Evangelos Briasoulis; Pericles Tsekeris
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

6.  Syndecan-4 Regulates Muscle Differentiation and Is Internalized from the Plasma Membrane during Myogenesis.

Authors:  Sissel B Rønning; Cathrine R Carlson; Espen Stang; Svein O Kolset; Kristin Hollung; Mona E Pedersen
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

7.  RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway.

Authors:  Loïc Maillard; Naoaki Saito; Hanna Hlawaty; Véronique Friand; Nadine Suffee; Fanny Chmilewsky; Oualid Haddad; Christelle Laguillier; Erwan Guyot; Takehiko Ueyama; Olivier Oudar; Angela Sutton; Nathalie Charnaux
Journal:  Biol Open       Date:  2014-09-26       Impact factor: 2.422

8.  A cytoplasmic C-terminal fragment of Syndecan-1 is generated by sequential proteolysis and antagonizes Syndecan-1 dependent lung tumor cell migration.

Authors:  Tobias Pasqualon; Jessica Pruessmeyer; Vera Jankowski; Aaron Babendreyer; Esther Groth; Julian Schumacher; Andrea Koenen; Sarah Weidenfeld; Nicole Schwarz; Bernd Denecke; Holger Jahr; Daniela Dreymueller; Joachim Jankowski; Andreas Ludwig
Journal:  Oncotarget       Date:  2015-10-13

9.  Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.

Authors:  Shuang Shi; Dong Zhong; Yao Xiao; Bing Wang; Wentao Wang; Fu'an Zhang; Haoyang Huang
Journal:  Oncotarget       Date:  2017-06-20

10.  Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade.

Authors:  Olivia García-Suárez; Beatriz García; Iván Fernández-Vega; Aurora Astudillo; Luis M Quirós
Journal:  Front Oncol       Date:  2014-02-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.